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Abstract
Background: Synchronous presentation of more than one germ cell tumours of different histology in the same patient is
considered to be very rare. In these cases of multiple germ cell tumours, strong theoretical and clinical data suggest an underlying
common pathogenetic mechanism concerning genetic instability or abnormalities during the pluripotent embryonic
differentiation and maturation of the germ cell.
Case presentation: A 25 year-old young man presented with an enlarging, slightly painful left cervical mass. Despite the initial
disorientation of the diagnosis to a possible thyroid disorder, the patient underwent complete surgical resection of the mass
revealing mediastinal choriocarcinoma. Subsequent ultrasound of the scrotum indicated the presence of a small lobular node in
the upper pole of the left testicle and the patient underwent radical left inguinal orchiectomy disclosing a typical seminoma. Based
on these results, the patient received 4 cycles of Bleomycin, Etoposide and Platinum chemotherapy experiencing only mild
toxicity and resulting in complete ongoing clinical and biochemical remission.
Conclusion: The pathogenesis of concurrent germ cell tumours in the same patient remains an area of controversy. Although
the genetic instability of the pluripotent germ cell offers an adequate explanation, the possibility of metastasis from the primary,
less differentiated tumour to a distant location as a more mature subtype cannot be excluded. Possible development of a
metastatic site of different histology and thus biological behaviour (e.g choriocarcinoma) should be anticipated. Furthermore,
urologists, pathologists and medical oncologists should be meticulous in the original pathological diagnosis in these patients, since
there is a significant frequency of germ cell tumours with mixed or overlapping histological elements with diverse potential of
evolution and differentiation.
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Background
Synchronous presentation of more than one germ cell
tumors (GCTs) in the same patient is considered to be
quite rare. It usually involves almost identical histological
subtypes, the possibility of metastasis from the one site to
another being the most probable explanation [1]. Here we
describe a case of concurrent presentation of left testicular
seminoma and choriocarcinoma of the upper mediasti-
num presenting as an enlarging, painless, left cervical
mass.
Case presentation
A 25-year-old male was presented in October 2004 with a
monthly history of a gradually enlarging, painless, left cer-
vical mass. He had no history of prior thyroid disorder or
other disease. Clinically the mass was hard in palpation,
firmly attached to the surrounding tissues and was located
at the anatomic area of the carotide triangle. Thorough
physical examination revealed only a marginal hepatome-
galy and splenomegaly. Routine blood tests, biochemical
markers and thyroid function tests – including triiodothy-
ronine (T3), thyroid stimulating hormone (TSH), thyre-
oglobulin and anti-thyroid antibodies- were within
normal limits, with the exception of a moderately ele-
vated erythrocyte sedimentation rate (ESR = 44). Subse-
quent cervical and thoracic CT scan revealed a
multilobular mass (4,3 × 4,7 × 7 cm) probably arising
from the left thyroid lobe, with infiltrating features and
heterogeneous density with regions of central necrosis
and hemorrhage. The mass submerged into the anterior-
posterior mediastinum, in proximity with the great vessels
of the heart, dislocating the left common carotid artery
and the left vagus nerve without infiltrating them (Fig. 1
and 2). Significant mediastinal lymphadenopathy was
also noted, whereas ultrasound of the abdomen excluded
liver involvement. Differential diagnosis included thyroid
carcinoma, lymphoma, thymoma, malignant congenital
branchiac cyst or cystic hygroma and germ cell tumours of
the upper mediastinum. Fine-needle aspiration biopsy of
the cervical mass was performed and the cytological find-
ings were consistent with papillary thyroid carcinoma
with anaplastic features. Based on these findings, the
patient was referred for surgical removal of the lesion. At
surgery, a large mass, measuring 9,5 × 6,3 × 4,5 cm was
found behind the left srenocleidomastoid muscle, located
lateral to the left carotid artery/jugular vein and was not
firmly adhered to the left thyroid lobe. The mass was eas-
ily separated from the surrounded tissues and was
removed. Based on the results of preoperative fine needle
aspiration biopsy, a total thyroidectomy was performed at
the same time. Pathology examination of the mass
revealed extensive infiltration by large or giant malignant
cells with morphological features consistent with syncyti-
otrophoblasts within necrotic and hemorrhagic elements
(Fig. 3A). Positive immunohistochemical staining with β-
subunit of human chorionic gonadotrophin (β-hCG) sug-
gested the diagnosis of choriocarcinoma of the upper
mediastinum (Fig. 3B). The pre-operation serum concen-
tration of β-hCG was >100.000 mIU/ml, whereas the
immediate post-operation levels declined to 17.300 mIU/
ml. Alpha- fetoprotein (a-FP) and carcinoembryonic anti-
gen (CEA) levels were within normal limits, while lactate
dehydrogenase (LDH) level was two-fold higher than the
normal upper limit. Based on these data, scrotal ultra-
sound examination was performed, disclosing a small
multilobular mass measuring 2,1 cm in greatest diameter-
not evident at previously performed physical examina-
tion- located on the upper pole of the left testicle with
echomorphological and hemodynamic characteristics
consistent with seminomatous tumour. Subsequently, the
patient underwent left radical inguinal orchiectomy with
high ligation of the left spermatic cord and implantation
of synthetic testicular prothesis. Histological diagnosis of
the testicular tumour revealed almost typical seminoma
(1,8 × 1,2 × 1 cm) consisting of large clear-cytoplasm cells
with hypodense nucleus and a few atypical mitosis, with-
out any signs of infiltration of rete testis or the spermatic
cord. Complete inhibition of spermatogenesis and hyper-
plastic reaction of Leydig cells were also observed (Fig.
4A). Although immunohistochemical staining for β-hCG
was positive in a few cells, their morphological character-
istics did not meet the diagnostic criteria for syncytiotro-
phoblasts (Fig. 4B). On postoperative day six (6), the
patient developed slightly painful cervical mass at the ana-
tomic site of the first surgical intervention and β-hCG lev-
els started rising up again (β-hCG = 29.850 mIU/ml) (Fig.
5). Complete pre-therapeutic staging was immediately
performed, including negative CT scan of the brain and
negative bone scan, whereas CT scan of the thorax and the
abdomen disclosed multiple round metastatic nodules of
various size (0,1 – 2 cm) in both lungs and marginally
enlarged iliac and para-aortic lymph nodes without liver
or other parenchymal organ involvement. In November
2004, one month after his initial admission to the hospi-
tal, the patient received 1st line chemotherapy for high-risk
germ cell tumour with the BEP regimen (Bleomycin 30
mg: d1-d8-d15, Etoposide 100 mg/m2: d1-d5 and Cisplatin
20 mg/m2: d1-d5 in 21-day cycles). Pre-chemotherapy lev-
els of β-hCG were 93.400 mIU/ml. The patient completed
4 cycles of therapy without experiencing remarkable tox-
icity (Neutropenia grade I-II according to the NCI-CTC
criteria) and is currently (October 2006) asymptomatic,
with ongoing complete clinical and biochemical remis-
sion according to the RECIST criteria (No evidence of
tumour mass, regression of all enlarged lymph nodes,
necrotic post-chemotherapy elements in the remaining
lung nodules confirmed by CT-guided fine-needle aspira-
tion biopsy and PET scan and consecutively normal levels
of β-hCG). A schematic presentation of the whole diagno-BMC Clinical Pathology 2006, 6:8 http://www.biomedcentral.com/1472-6890/6/8
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sis and treatment course including β-hCG titer and chest
Xray findings is illustrated in Fig. 5
Discussion
GCTs are generally malignant and represent 93% of all
testicular neoplasms [1]. At least half of them are of sem-
inomatous cell origin, being either "typical" seminomas
or containing mixed elements of non-seminomatous ori-
gin (embryonal or choriocarcinoma elements such as syn-
cytiotrophoblasts) which do not usually affect the good
prognosis of seminomas [2]. On the other hand, non-
seminomatous GCTs, represent a more heterogenous
group comprising four main subtypes (embryonal carci-
noma, teratoma, choriocarcinoma and yolk sac tumor)
with significant overlapping and increased frequency of
mixed histological pictures [3].
It is thought today that these common histological ele-
ments between seminomatous and non-seminomatous
GCTs and also between the different subtypes of non-sem-
inomatous GCTs reflect their common embryonic origin
from the same primitive, pluripotent germ cell which has
the capacity to mature and differentiate to neoplastic
endodermal or ectodermal components, imitating thus
the procedures of normal embryonic development [1].
Consequently, each type of germinal cancer is considered
to be the "counterpart" of each stage of normal embryo
development: Seminoma is the neoplastic counterpart of
the spermatocyte and represents the more undifferenti-
ated type. The next stage is that of the fertilized ovum and
the formation of the blastocele which gives rise to both
the embryo and the placenta: the neoplastic counterpart is
the embryonal cell carcinoma, which produces high levels
of a-FP concentration. At a more mature stage of embry-
onic development, malignant transformation of the
developing embryo will lead to teratomas (a-FP and β-
hCG production), whereas neoplastic transformation of
the embryonic yolk sac cells leads to the homonymous
tumours, overproducing a-FP. Finally, syncytiotrophob-
lastic and cytotrophoblastic components of the placenta
will give rise to pure choriocarcinomas, that overproduce
β-hCG. Although choriocarcinomas represent a more dif-
ferentiated malignant counterpart, they are characterised
by an aggressive biological behaviour with tendency for
haematogenous metastasis, probably reflecting the capac-
ity of its normal counterpart (the placenta) to invade
blood vessels [4]. The last observation suggests that malig-
nant transformation of a more mature element during
embryonic development does not necessarily predict
either a benign biological behaviour of the tumour or a
more favourable clinical outcome.
CT scan of the cervix revealing a large mass (red arrows), 14  cm in greatest diameter extending from the left carotide tri- angle to the anterior-posterior mediastinum, in proximity  with the great vessels of the heart, dislocating the left com- mon carotid artery (yellow arrows) and the left vagus nerve  without infiltrating them Figure 1
CT scan of the cervix revealing a large mass (red arrows), 14 
cm in greatest diameter extending from the left carotide tri-
angle to the anterior-posterior mediastinum, in proximity 
with the great vessels of the heart, dislocating the left com-
mon carotid artery (yellow arrows) and the left vagus nerve 
without infiltrating them.
CT scan of the upper mediastinum (complementary to figure  1) Figure 2
CT scan of the upper mediastinum (complementary to figure 
1).BMC Clinical Pathology 2006, 6:8 http://www.biomedcentral.com/1472-6890/6/8
Page 4 of 7
(page number not for citation purposes)
Based on the above mentioned data, the hypothesis that
the concomitant development of two different histologi-
cal types of germ cell tumour in the same patient is ran-
dom, does not seem probable. Interestingly, synchronous
or metachronous development of multiple germ cell
tumours in the same patient insinuates an underlying
common pathogenetic mechanism concerning genetic
instability or abnormalities during the pluripotent embry-
onic germ cell differentiation and maturation. A number
of genetic abnormalities, the most common being iso-
chromosome 12, have been described in patients with
germ cell tumours and have also been implemented in the
diagnostic procedure of undifferentiated mediastinal
tumours of uncertain histological origin [5]. It seems that
germ cells of the testicles (or the ovaries), as well as the
primitive embryonic germ cells that have remained in
extragonadal locations in the midline of the body (medi-
astinum, retroperitoneum), can undergo malignant trans-
formation and mimic procedures of normal embryonic
development by differentiating towards various embry-
onic or extra-embryonic elements.
Recently, it has been suggested that the synchronous or
metachronous presentation of different types of GCTs in
the same patient does not indicate two different primary
tumours with common pathogenetic origin, but the more
differentiated site might represent a possible metastatic
location of the primary undifferentiated tumour, which
has metastasised as a more mature type [4]. Interestingly
enough, this histological "conversion" into a more differ-
entiated type at the metastatic location has been observed
A. Testicular seminoma: Uniform tumor cells with abundant  clear cytoplasm and centrally located nucleus Figure 4
A. Testicular seminoma: Uniform tumor cells with abundant 
clear cytoplasm and centrally located nucleus. Tumor nests 
are outlined by fibrous bands infiltrated by lymphocytes. 
(medium power magnification). 4B: Rare cells stain positive 
for β-hCG (high power magnification).
 
 
 
A. Mediastinal choriocarcinoma: Diffuse sheets of cytotroph- blastic and syncytiotrophoblastic cells Figure 3
A. Mediastinal choriocarcinoma: Diffuse sheets of cytotroph-
blastic and syncytiotrophoblastic cells. Hemorrhagic and 
necrotic locations are also seen. (medium power magnifica-
tion) B. Tumor cells with diffuse positive cytoplasmic immu-
nostaining for β-hCG.(High power magnification).BMC Clinical Pathology 2006, 6:8 http://www.biomedcentral.com/1472-6890/6/8
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in a few series of patients with GCTs [6]. We know today
that metastatic sites are not always histologically identical
with the primary location: histological conversion can
occur, either as a normal maturation procedure mimick-
ing embryonic development or as a result of therapeutic
intervention. In the last case, chemotherapy can destroy
the rapidly growing, chemosensitive embryonal compo-
nents of a mixed GCT, sparing the more resistant ter-
atomatous elements and resulting thus in a completely
different histology compared to that of the primary
tumour location [4].
The above mentioned hypothesis implies that GCTs may
metastasise only as a more mature histological type in the
procedure of embryogenesis and never in the opposite
direction, which has been confirmed by numerous clini-
cal observations: Metastases from embryonic carcinomas
may be found to consist of both teratoma and choriocar-
cinoma elements, whereas choriocarcinomas metastasise
only as choriocarcinomas, since they represent the more
differentiated histological type of embryonic develop-
ment [6]. Seminomas possess the theoretical capacity of
metastasising as various histological components since
they represent the malignant counterpart of the more
"primitive" cell, the spermatocyte. However, some
authors suggest that "typical" seminomas always metasta-
sise keeping their original histological features: those who
do not are believed to represent GCTs of mixed histology,
misdiagnosed as seminomas at the original histological
examination. Supporters of this theory believe that histo-
logical "conversion" can not happen either automatically
or after therapeutic intervention. Ayala and Ro suggest
that all GCTs, including seminomas, consist of all embry-
onic elements, not always detectable at initial pathology
examination and have thus the potential of giving rise to
histologically different metastases consisting of one of the
primary tumour elements, depending on their different
metastatic potential and the therapeutic intervention
including chemotherapy and radiotherapy [1].
Our patient developed almost concurrently testicular
seminoma and pure choriocarcinoma of the mediasti-
num. Histological "conversion" of the original tumour
site is theoretically possible since choriocarcinoma repre-
sents a more mature stage of embryonic development
compared to seminoma. On the other hand, one could
argue that the primary tumour was not a typical semi-
noma and that chorionic elements where present at the
original histological examination including few giant cells
with positive immunohistochemistry for β-hCG. Never-
theless, trophobalstic elements, whose presence is consid-
ered to be mandatory for the diagnosis of
choriocarcinoma, were totally absent in the original
pathology specimen.
The above mentioned potential of GCTs to metastasise as
a more differentiated subtype is clinically meaningful,
since the clinician should anticipate possible develop-
ment of a metastatic site of a more aggressive biological
behaviour (e.g. choriocarcinoma) compared to that of the
original location. Thus, medical oncologists, urologists
and pathologists should be very suspicious of the original
pathological diagnosis in these patients, since there is a
significant frequency of GCTs with mixed or overlapping
histological elements with diverse potential of evolution
and differentiation. Moreover, given the heterogeneity of
these tumours, one could emphasize the necessity of
obtaining multiple samples from different tumour areas
in every case of GCT so as to minimize the risk of missing
important particular components of the tumour who
could potentially affect the diagnosis, prognosis or even
the therapeutic intervention.
The presenting symptom of our patient was an enlarging,
painless cervical mass, originally thought to be a thyroid
node and is considered to be an extremely rare presenta-
tion. With the exception of choriocarcinoma, which gives
early haematogenous metastases, testicular tumours usu-
ally become apparent in their primary location with pain-
less or slightly painful enlargement of the testicle noticed
accidentally by the patient himself. Discolo and Dis-
paquale reported a case of testicular seminoma with cervi-
cal lymphadenopathy as the presenting symptom [7].
Costal bones, brain, spleen, paracolic gutter, urethra, infe-
rior vena cava, pancreatic and subcutaneous tissue have
been reported as rare metastatic locations of primary tes-
ticular cancer but not as the presenting manifestation [8-
14] (table 1). In our patient the painless cervical enlarge-
ment was due to the growing mediastinal choriocarci-
noma and is, to our knowledge, the first case of
concurrent testicular seminoma and mediastinal chorio-
carcinoma ever reported. The unusual location, along
with the results of fine-needle aspiration biopsy disorien-
tated initially the diagnosis towards malignancy of the
thyroid gland. Thyroid carcinoma with anaplastic features
is considered to be extremely rare in young males and the
clinician should be very suspicious in every mediastinal
mass of uncertain histology in young adults. Detailed
examination of the testicles including scrotal ultrasound
with Doppler angiography should be performed in every
diagnosed or highly suspected extra-gonadal germ cell
tumour, as the latter could represent a possible metastatic
site. Complete staging along with solid histological con-
firmation in both tumour locations are mandatory before
any therapeutic intervention is initiated.
Conclusion
Germ cell tumours represent a heterogeneous group of
malignant cell lines with a variety of frequently overlap-
ping histological pictures or with mixed components sug-BMC Clinical Pathology 2006, 6:8 http://www.biomedcentral.com/1472-6890/6/8
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Schematic presentation of the diagnosis and treatment course, including β-CG title and X-ray findings Figure 5
Schematic presentation of the diagnosis and treatment course, including β-CG title and X-ray findings. FNAB: fine-needle aspi-
ration biopsy.
Initial presentation
(October 2004)
    1
st Intervention (Excision of thoracic mass)
2
nd Intervention (Left inguinal orchiectomy)
4 cycles of BEP chemotherapy
(November-December 2004
ȕ-hCG=93.400 mIU/ml
Cervical mass at the area of 1
st
intervention
Thoracic X-ray: multiple metastatic
nodules
ȕ-hCG=17.300 mIU/ml
Thoracic X-ray: No findings 
Testicular mass
Mediastinal and cervical mass
ȕ-hCG > 100.000 mIU/ml
Thoracic X-ray : Mediastinal
lymhadenopathy
Current situation
(September 2006)
ȕ-hCG<0,2 mIU/ml
Clinical complete remission
Thoracic X-ray: Necrotic post 
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gesting a common "precursor" embryonic cell
dysfunction. Histological conversion to a more mature
subtype is theoretically possible in a metastatic location
with or without therapeutic intervention, as well as syn-
chronous or metachronous development of two different
primary germ cell tumours as a result of a common patho-
genetic mechanism concerning genetic instability or
abnormalities during the pluripotent embryonic germ cell
differentiation and maturation.
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Table 1: Summary of the published cases of synchronous or metachronous development of second GCT in patients with primary 
testicular cancer.
TYPE OF PRESENTATION LOCALISATION OF SECOND TUMOUR HISTOLOGY OF SECOND TUMOUR REFERENCE
Metachronous Costal bones SGCT [8]
Metachronous Brain and Spleen NSGCT [9]
Metachronous Paracolic SGCT [10]
Synchronous IVC and GI SGCT [11]
Metachronous Pancreas NSGCT [12]
Synchronous Mediastinal NSGCT [13]
Metachronous Subcutaneous NSGCT [14]
SGCT: seminomatous germ-cell tumours, NSGCT: non-seminomatous germ-cell tumours, IVC: inferior vena cava, GI: Gastro-intestinal tract.